958 results match your criteria: "Department of Internal Medicine and Clinical Immunology.[Affiliation]"

Characterisation of airway disease associated with Sjögren disease.

RMD Open

February 2024

Department of Rheumatology, Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre, France

Objective: Although airway disease associated with Sjögren's disease (Sjo-AD) is common, it is poorly studied compared with interstitial lung disease (ILD). In this study, we aimed to assess factors associated with Sjo-AD, the characteristics and prognosis of this manifestation.

Methods: We performed a retrospective multicentric study involving nine centres.

View Article and Find Full Text PDF

Objectives: VEXAS syndrome is an autoinflammatory disease associated with a somatic mutation of the X-linked UBA1 gene in haematopoietic progenitor cells. This disorder was originally described as a disease affecting men, but rare cases of VEXAS syndrome in women have since been reported. The theoretical existence of phenotypic sex differences in this X-linked disease is debated.

View Article and Find Full Text PDF

Laboratory tests for investigating anemia: From an expert system to artificial intelligence.

Pract Lab Med

March 2024

Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005, Paris, France.

Objective: To compare the laboratory tests conducted in real-life settings for patients with anemia with the expected prescriptions derived from an optimal checkup.

Methods: A panel of experts formulated an "optimal laboratory test assessment" specific to each anemia profile. A retrospective analysis was done of the laboratory tests conducted according to the type of anemia (microcytic, normocytic or macrocytic).

View Article and Find Full Text PDF

Systemic sclerosis, silica exposure and cellular therapies: The sand in the gears?

Rev Med Interne

July 2024

Unité de médecine interne (UF04): CRMR MATHEC, maladies auto-immunes et thérapie cellulaire, centre de référence des maladies auto-immunes systémiques rares d'Île-de-France, recherche clinique en hématologie, immunologie et transplantation, URP3518, hôpital St-Louis, AP-HP, université Paris Cité, IRSL, 75010 Paris, France; Department of Medicine, McGill University, H3A 1A1 Montreal, Canada.

Systemic sclerosis (SSc) is a chronic orphan autoimmune disease with the highest mortality rate among rheumatic diseases. SSc-related interstitial-lung disease (ILD) remains among the leading causes of SSc-related mortality with still few therapeutic effective strategies. In patients with crystallin silica exposure, SSc is recognized as an occupational disease according to the French social security system (Table 25A of the general insurance regimen).

View Article and Find Full Text PDF

Background: VEXAS (Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is caused by acquired somatic mutations in UBA1. Sweet-syndrome-like skin disorders [and especially histiocytoid Sweet syndrome (HSS)] may be associated with VEXAS syndrome.

Objectives: To characterize the clinical and histopathological features of HSS in patients with VEXAS syndrome.

View Article and Find Full Text PDF

Genome sequencing identify chromosome 9 inversions disrupting ENG in 2 unrelated HHT families.

Eur J Med Genet

April 2024

Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France; Laboratoire AURAGEN, Lyon, France. Electronic address:

Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber disease, is a dominant inherited vascular disorder. The clinical diagnosis is based on the Curaçao criteria and pathogenic variants in the ENG and ACVRL1 genes are responsible for most cases of HHT. Four families with a negative targeted gene panel and selected by a multidisciplinary team were selected and whole-genome sequencing was performed according to the recommendations of the French National Plan for Genomic Medicine.

View Article and Find Full Text PDF

Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis.

Mol Aspects Med

April 2024

UCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, Department of Inflammation, London, UK. Electronic address:

Systemic sclerosis (also called scleroderma, SSc) is a chronic autoimmune disorder characterized by excessive collagen deposition leading to skin fibrosis and various internal organ manifestations. The emergent diagnostics and therapeutic strategies for scleroderma focus on early detection and targeted interventions to improve patient outcomes and quality of life. Diagnostics for SSc have evolved significantly in recent years, driven by advancements in serological markers and imaging techniques.

View Article and Find Full Text PDF

Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome.

Eur J Intern Med

May 2024

Laboratoire de Génétique des Maladies rares et autoinflammatoires, Service de Génétique moléculaire et cytogénomique, CHU Montpellier, Univ Montpellier, CeRéMAIA, Montpellier, France.

View Article and Find Full Text PDF

Prevalence of iron deficiency in patients admitted to a geriatric unit: a multicenter cross-sectional study.

BMC Geriatr

January 2024

UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Sorbonne Universités, UPMC Univ Paris 06, Paris, France.

Article Synopsis
  • - The CARENFER PA study aimed to assess the prevalence of iron deficiency (ID) in older patients (over 75 years) in geriatric units, finding a high ID prevalence of 57.6% among 888 patients studied.
  • - The study revealed that ID was more common in patients with multiple comorbidities and elevated levels of inflammation, as indicated by CRP levels, with CRP being a strong predictor of ID.
  • - Additionally, older patients with ID performed worse on the Short Physical Performance Battery (SPPB) test, indicating a higher risk of adverse outcomes such as disability and falls compared to those without ID.
View Article and Find Full Text PDF
Article Synopsis
  • Congenital erythropoietic porphyria (CEP) is a rare genetic disorder resulting from a deficiency in an enzyme crucial for heme biosynthesis, leading to varying severity levels from life-threatening symptoms at birth to milder issues later on.
  • A study reviewed 20 severe perinatal cases of CEP in France, analyzing their presentation and progression through data collected from medical records.
  • Key findings revealed diverse outcomes: some cases involved severe antenatal symptoms like hydrops fetalis and resulted in early mortality, while others showed acute neonatal distress from severe anemia and required hematopoietic stem cell transplantation, which had mixed success rates, highlighting the urgency for improved prenatal and postnatal care strategies.
View Article and Find Full Text PDF

Successful Introduction of Benralizumab for Eosinophilic Ascites.

Biomedicines

January 2024

Department of Internal Medicine and Clinical Immunology, University Hospital of Lille, 59037 Lille, France.

Eosinophilic ascites is a rare disorder, reported in both adult and pediatric patients, characterized by high eosinophil counts in the peritoneal fluid. Eosinophilic ascites appears as a manifestation of various diseases such as parasitic and fungal infections, malignancy, and hypereosinophilic syndrome. It also represents an uncommon manifestation of eosinophilic gastroenteritis, usually treated with corticosteroids.

View Article and Find Full Text PDF

Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine.

Lancet Rheumatol

November 2023

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Division of Rheumatology, AOUC, Florence, Italy; Unit of Immunology, Rheumatology, Allergy, and Rare diseases, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

Article Synopsis
  • Scientists are trying to find a way to identify people who might get a disease called systemic sclerosis before it shows any serious symptoms.
  • This early stage of the disease is called "pre-scleroderma," and it's important because it happens before the damage to skin or organs becomes permanent.
  • The article suggests that understanding this early stage could help doctors treat patients sooner, preventing serious problems related to the disease.
View Article and Find Full Text PDF
Article Synopsis
  • - The RISE-SSc trial studied the safety and effectiveness of riociguat for treating early diffuse cutaneous systemic sclerosis, comparing it to a placebo and then evaluating long-term effects for an additional year.
  • - Out of 121 patients in the main study, 87 (72%) enrolled in the long-term extension, with a majority being women and White, which led to the observation that 94% experienced mild to moderate adverse events, but no new serious complications emerged.
  • - The study concluded that riociguat remained safe over the long term, although it lacked a comparator group in its open-label phase, which is a noted limitation.
View Article and Find Full Text PDF

: To explore a possible connection between active viral infections and manifestation of dermatomyositis (DM). Skeletal muscle biopsies were analyzed from patients diagnosed with juvenile (n=10) and adult (n=12) DM. Adult DM patients harbored autoantibodies against either TIF-1γ (n=7) or MDA5 (n=5).

View Article and Find Full Text PDF
Article Synopsis
  • McGonagle and McDermott propose a classification of autoimmune and autoinflammatory diseases as a continuum, highlighting the interplay between purely autoimmune, purely autoinflammatory, and mixed disease types based on genetic associations.
  • Researchers analyzed blood samples from 443 patients with 15 different autoimmune or autoinflammatory diseases and 71 healthy individuals, utilizing deep immunophenotyping to identify immune cell populations through various flow cytometry techniques.
  • Findings revealed five disease clusters based on immune cell characteristics, linked to inflammation levels and affected tissues, with implications for better defining targeted therapies and warranting further research into specific immune cell interactions.
View Article and Find Full Text PDF

Background: Vascular phenotype is associated with a poor prognosis in systemic sclerosis (SSc). The identification of its risk factors could facilitate its early detection.

Objectives: To explore risk factors for a vascular phenotype of SSc, among them a history of pre-eclampsia.

View Article and Find Full Text PDF

Introduction: Stevens-Johnson syndrome (SJS), Stevens-Johnson/toxic epidermal necrolysis overlap syndrome (SJS/TEN) and toxic epidermal necrolysis (TEN) are rare, acute, potentially lethal conditions, considered to be part of the severe cutaneous adverse reactions (SCARs) spectrum, with TEN being the most life-threatening. The distinction between these three entities is based on the extent of total skin surface involvement, with SJS involving < 10%, SJS/TEN involving 10-30% and TEN involving > 30% of total body surface area. These mucocutaneous reactions are most commonly caused by a hypersensitivity reaction to a drug, with infections and vaccines being possible, less common etiologies.

View Article and Find Full Text PDF

Defining the course of neurosarcoidosis according to presentation at onset and disease modifying treatment: a cohort study of 84 patients.

Ther Adv Neurol Disord

December 2023

Service de Neurologie, Hopital Central, CHRU de Nancy, 1 Avenue du Maréchal de Lattre de Tassigny, Nancy 54000, France.

Background: Neurosarcoidosis is a rare manifestation of sarcoidosis with heterogeneous presentations. Patient management is challenging due to the current lack of knowledge about the long-term disease course.

Objective: To identify specific disease courses of neurosarcoidosis according to the clinical and paraclinical presentations at onset.

View Article and Find Full Text PDF

We did not identify any vacuole-related differences in circulating immature myeloid cells between VEXAS patients and UBA1-WT 'VEXAS-like' patients. The similar vacuolization of circulating immature myeloid cells between VEXAS and UBA1-WT patients is explained by the main bloodstream passage of late precursors, in which the vacuolization is already similar in bone marrow in both cases.

View Article and Find Full Text PDF

FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis.

Cell Rep Med

December 2023

Institut Necker Enfants Malades, INSERM U1151, CNRS UMR-8253, Université Paris Cité, Paris, France; Sorbonne Université, INSERM, UMR_S959, Immunology-Immunopathology-Immunotherapy, Paris, France; Université Paris Cité, Faculté de Médecine, Paris, France. Electronic address:

FLT3-L-dependent classical dendritic cells (cDCs) recruit anti-tumor and tumor-protecting lymphocytes. We evaluate cancer growth in mice with low, normal, or high levels of cDCs. Paradoxically, both low or high numbers of cDCs improve survival in mice with melanoma.

View Article and Find Full Text PDF

Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.

J Autoimmun

January 2024

Department of Internal Medicine and Clinical Immunology, Referral Center for Rare Autoimmune and Autoinflammatory Diseases (MAIS), Dijon University Hospital, Dijon, France; Université Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-21000, Dijon, France. Electronic address:

Vascular smooth muscle cells (VSMCs) have been shown to play a role in the pathogenesis of giant cell arteritis (GCA) through their capacity to produce chemokines recruiting T cells and monocytes in the arterial wall and their ability to migrate and proliferate in the neointima where they acquire a myofibroblast (MF) phenotype, leading to vascular stenosis. This study aimed to investigate if MFs could also impact T-cell polarization. Confocal microscopy was used to analyze fresh fragments of temporal artery biopsies (TABs).

View Article and Find Full Text PDF

[F]FDG PET-MR characterization of aortitis in the IL1rn mouse model of giant-cell arteritis.

EJNMMI Res

November 2023

Department of Internal Medicine and Clinical Immunology, Normandie University, UNICAEN, CHU de Caen Normandie - Université Basse Normandie, Avenue de la Côte de Nacre, 14000, CAEN, France.

Background: Metabolic imaging is routinely used to demonstrate aortitis in patients with giant-cell arteritis. We aimed to investigate the preclinical model of aortitis in BALB/c IL1rn mice using [F]fluorodeoxyglucose ([F]FDG) positron emission tomography-magnetic resonance (PET-MR), gamma counting and immunostaining. We used 15 first-generation specific and opportunistic pathogen-free (SOPF) 9-week-old IL1rn mice, 15 wild-type BALB/cAnN mice and 5 s-generation specific pathogen-free (SPF) 9-week-old IL1rn.

View Article and Find Full Text PDF